Investors / United States / 7G BioVentures
7G BioVentures
Venture capital · Burlingame, CA, United States · North America
7G BioVentures is a venture fund focused on first-in-class life science innovations. It works with scientists, clinicians and entrepreneurs to translate discoveries into products.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechhealthcare
Your fit with 7G BioVentures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fits7G BioVentures lists 11 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Anzu Partners, Boutique Venture Partners and Cornucopian Capital.
No funding round on record names 7G BioVentures yet, so the figures come from its portfolio page.
Round figures show recent activity, not 7G BioVentures' whole history. Rounds on record name 0 companies; its own site lists 11. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 27th | 11 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 20th | 1 country |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers11100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare 7G BioVentures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
11 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Azora Therapeutics develops therapies for serious immune-mediated and inflammatory diseases, including ulcerative colitis. | Healthcare & Biotech | Portfolio page | ||
| BBy is revolutionizing the way hospitals manage, store and administer breast milk to infants. | Healthcare & Biotech | Portfolio page | ||
| Curbside turns guidelines, protocols, and policies into governed, interactive decision support for healthcare providers. | Healthcare & Biotech | Portfolio page | ||
| Epion Therapeutics is developing a minimally-invasive treatment for ectatic corneal disease | Healthcare & Biotech | Portfolio page | ||
| The company develops biologics and peptides for various diseases, including obesity and cardio-renal-metabolic diseases. | Healthcare & Biotech | Portfolio page | ||
| Imviva is a clinical-stage biotechnology company that engineers allogeneic CAR-T cell therapies for cancers and autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
| Kayothera develops small molecule inhibitors of the retinoid nuclear receptor pathway for unmet medical needs | Healthcare & Biotech | Portfolio page | ||
| Mesentech is developing prostaglandin prodrugs for musculoskeletal regeneration. | Healthcare & Biotech | Portfolio page | ||
| Optimeos develops a solution suite to overcome formulation challenges and address unmet medical needs in drug delivery, enabling the use of biologics, peptides and RNA to treat disease. | Healthcare & Biotech | Portfolio page | ||
| Perseo Pharma AG develops oral enzyme therapies to help patients suffering from digestive diseases | Healthcare & Biotech | Portfolio page | ||
| The company develops touch-based sweat sensing technology for health purposes. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- 7gventures.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 11
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get 7G BioVentures' profile as data
Pull 7G BioVentures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/7gventures.com
# also
GET /v1/firms/7gventures.com/portfolio
GET /v1/firms/7gventures.com/coinvestors
GET /v1/firms/7gventures.com/news